Iseq heavyweight CRH had another good day. Photograph: Brenda Fitzsimons

European shares eased back yesterday, having already recouped nearly all their losses from a bruising 8 per cent drop earlier this week, with markets(...)

The drug flibanserin, under the trade name Addyi, nicknamed “female Viagra” is shown in this undated Sprout Pharmaceuticals handout photograph released on Tuesday. Photograph: Sprout Pharmaceuticals/Reuters. 1:19

The first drug to treat low sexual desire in women won approval from US health regulators on Tuesday, but with a warning about potentially dangerous l(...)

Des Higgins, who developed Clustal, in 2002. Photograph: Michael Mac Sweeney/Provision

We are not always good at telling the stories of Irish scientists and the impact of their work. One of these stories concerns the extraordinary imp(...)

US doctors and teaching hospitals got $6.49 billion from drug and medical-device makers in 2014, according to new government data .

US doctors and teaching hospitals got $6.49 billion from drug and medical-device makers in 2014, according to new government data on the financial lin(...)

Packets of medicines sit in a drawer inside a pharmacy store  in Athens, Greece. Photographer: Kostas Tsironis/Bloomberg

Drugmakers said on Monday they would continue to ship medicines to Greece in coming weeks, despite mounting unpaid bills, but warned supplies could be(...)

 Max Barrett (6) and Holly Barrett (3) at the Launch of the 10th Anniversary of the Pfizer Health Index. Photograph: Robbie Reynolds

The number of people paying for health insurance has risen for the first time in five years, with 36 per cent of people now holding health insurance p(...)

Maria Meehan, Research manager, Fighting Blindness

Dr Shane Bergin School of Physics, Trinity College Dublin In 1999 I came to Trinity College Dublin to study for a degree in science and, excluding a f(...)

Robert J. Coury, vice chairman and chief executive officer of Mylan told investors he may sweeten the company’s cash-and-stock offer for  Perrigo, which has rejected Mylan’s most recent offer of $75 in cash and 2.3 Mylan shares for each Perrigo share. (Photograph: Mannie Garcia/Bloomberg News)

Mylan’s chairman told investors he may sweeten the company’s cash-and-stock offer for Irish headquartered Perrigo by adding terms to reduce the risk (...)

Foreign pharmaceuticals companies in China have struggled with regulatory problems in recent years, including more stringent approval requirements

US drugmaker Pfizer has halted vaccine sales in China after an import licence for one of its top-selling treatments expired, dealing a blow to the com(...)

Nora Khaldi and Emmet Browne of Dublin-based bioinformatics company Nuritas.

Irish start-up Nuritas has appointed former Pfizer regional president Emmet Browne as chief executive.Mr Browne was previously the managing director o(...)